NUPATHE INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2013-08: Study NCT02684409; Company role Lead sponsor; Phase Phase 1; Status Completed.
- 2009-12: Study NCT01381796; Company role Lead sponsor; Phase Phase 1; Status Completed.
- 2009-02: Study NCT00806546; Company role Lead sponsor; Phase Phase 3; Status Completed.
- 2009-01: Study NCT00792103; Company role Lead sponsor; Phase Phase 3; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2013-08 | NCT02684409 Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine | Lead sponsor | Phase 1 | Completed | Acute Migraine | 37 | 2014-11 |
| 2009-12 | NCT01381796 Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults | Lead sponsor | Phase 1 | Completed | Compare Bioequivalence Patches Previously Used in the NP101-007 Study | 63 | 2010-09 |
| 2009-02 | NCT00806546 An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months | Lead sponsor | Phase 3 | Completed Results posted | Migraine Disorders | 514 | 2011-05 |
| 2009-01 | NCT00792103 An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months | Lead sponsor | Phase 3 | Completed Results posted | Migraine Disorders | 198 | 2010-09 |
| 2009-01 | NCT00724815 The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine | Lead sponsor | Phase 3 | Completed Results posted | Migraine Disorders | 530 | 2009-07 |
| 2008-11 | NCT00723983 Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period | Lead sponsor | Phase 1 | Completed | Migraine Disorders | 23 | 2009-09 |
| 2008-06 | NCT00720018 Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers | Lead sponsor | Phase 1 | Completed | Migraine Disorders | 4 | 2008-07 |
| 2007-11 | NCT00546650 Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex® | Lead sponsor | Phase 1 | Completed | Healthy | 25 | 2008-03 |